Tuoran Pharma

中科拓苒

Tuoran Pharma

Biotech/Healthcare

Zhongke Tuoran develops targeted novel therapeutics. Its proprietary innovative drug pipeline covers oncology, autoimmune diseases, and inflammatory conditions, with two Class 1 innovative drugs currently at the IND filing stage.

Latest round: Series B (2022)

Source: ChinaBulls — chinabulls.com

Last updated 2022-02-01